Study 301: Objective Response Rate,
Independent Review
Eribulin
(N=554)
Capecitabine
(N=548)
n (%)
n (%)
Objective response rate
61 (11.0)
63 (11.5)
95% CI
(8.5, 13.9)
(8.9, 14.5)
Fisher's Exact test p-value
0.849
Complete response (CR)
1 (0.2)
0 (0)
Partial response (PR)
60 (10.8)
63 (11.5)
Stable disease (SD)
313 (56.5)
303 (55.3)
Progressive disease (PD)
125 (22.6)
133 (24.3)
Not evaluable (NE)
11 (2.0)
6 (1.1)
Unknown
44 (7.9)
43 (7.8)
Clinical benefit rate (CBR)
145 (26.2)
147 (26.8)
95% CI
(22.6, 30.0)
(23.2, 30.7)
Fisher's Exact test p-value
0.838
